Colorectal Division of Surgical Ward, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
BMC Surg. 2023 Sep 1;23(1):263. doi: 10.1186/s12893-023-02166-5.
The etiology of LARS has not been elaborated on clearly. Studies have reported neoadjuvant therapy, low-lying rectal cancers, adjuvant therapy and anastomotic leakage as risk factors for the development of LARS. Anastomotic level has also been proposed as a possible risk factor; However, there have been conflicting results. This study aims to evaluate the role of the level of anastomosis as a potential risk factor for the development of LARS.
A systematic literature search was conducted on Pubmed, Scopus, Embase, and Web of Science databases using Mesh terms and non-Mesh terms from 2012 to 2023. Original English studies conducted on rectal cancer patients reporting of anastomotic level and LARS status were included in this study. Eligible studies were assessed regarding quality control with Joanna-Briggs Institute (JBI) questionnaires.
A total of 396 articles were found using the research queries, and after applying selection criteria 4 articles were selected. A sample population of 808 patients were included in this study with a mean age of 61.51 years with male patients consisting 59.28% of the cases. The Mean assessment time was 15.6 months which revealed a mean prevalence of 48.89% for LAR syndrome. Regression analysis revealed significantly increased risk of LAR syndrome development due to low anastomosis level in all 4 studies with odds ratios of 5.336 (95% CI:3.197-8.907), 3.76 (95% CI: 1.34-10.61), 1.145 (95% CI: 1.141-2.149) and 2.11 (95% CI: 1.05-4.27) for low anastomoses and 4.34 (95% CI: 1.05-18.04) for ultralow anastomoses.
LARS is a long-term complication following surgery, leading to reduced quality of life. Low anastomosis level has been reported as a possible risk factor. All of the studies in this systematic review were associated with an increased risk of LARS development among patients with low anastomosis.
LARS 的病因尚未得到明确阐述。研究报告称新辅助治疗、低位直肠癌、辅助治疗和吻合口漏是 LARS 发展的危险因素。吻合口水平也被提出可能是一个危险因素;然而,结果存在矛盾。本研究旨在评估吻合口水平作为 LARS 发展的潜在危险因素的作用。
使用 Mesh 术语和非 Mesh 术语,从 2012 年至 2023 年,在 Pubmed、Scopus、Embase 和 Web of Science 数据库中进行系统文献检索。本研究纳入了报告直肠癌患者吻合口水平和 LARS 状态的原始英文研究。使用 Joanna-Briggs 研究所(JBI)问卷评估合格研究的质量控制。
使用研究查询共发现 396 篇文章,应用选择标准后,选择了 4 篇文章。本研究共纳入 808 例患者,平均年龄 61.51 岁,男性占 59.28%。平均评估时间为 15.6 个月,显示 LAR 综合征的平均患病率为 48.89%。回归分析显示,在所有 4 项研究中,低吻合口水平与 LAR 综合征发展的风险显著增加,比值比分别为 5.336(95%CI:3.197-8.907)、3.76(95%CI:1.34-10.61)、1.145(95%CI:1.141-2.149)和 2.11(95%CI:1.05-4.27),低位吻合口和超低吻合口的比值比分别为 4.34(95%CI:1.05-18.04)。
LARS 是手术后的一种长期并发症,导致生活质量下降。低吻合口水平已被报道为可能的危险因素。本系统评价中的所有研究都与低位吻合口患者 LARS 发展风险增加有关。